欢迎访问行业研究报告数据库

报告分类

重点报告推荐

当前位置:首页 > 行业导航

找到报告 33769 篇 当前为第 21 页 共 3377

所属行业:医药制造业

  • 201.全球临床决策支持系统 CDSS 市场报告

    [信息传输、软件和信息技术服务业,医药制造业] [2024-07-31]

    A clinical decision support system (CDSS) is a type of health information technology that offers knowledge and person-specific data to physicians, employees, patients, and other individuals to support health and medical care. A wide range of tools are included in CDSS to improve clinical workflow decision-making. These tools include, among others, focused patient data reports and summaries, documentation templates, diagnostic support, and contextually relevant reference data.

    关键词:临床决策支持系统 (CDSS) ;医疗信息技术;提供知识;个人特定数据;支持健康;医疗保健
  • 202.全球骨空隙填充物市场报告

    [化学纤维制造业,医药制造业] [2024-07-31]

    Nearly 10 million individuals above the age of 50 suffer from hip, spine, or wrist fractures at some point in life. An additional 33.6 million individuals develop low bone mass and are at risk of osteoporosis. The growing number of complications related to bone-associated disorders such as fractures, traumas, bone infections, and bone tumors has led to the increasing demand for bone void fillers. The bone void fillers have become an indispensable tool for surgeons to manage and treat bone disorders. With the growing prevalence of bone-related diseases and accidents, many leading companies are introducing innovative solutions to provide patients with highquality bone void fillers to achieve the best outcomes.

    关键词:受髋部;脊柱;腕部骨折;骨质疏松症的风险;骨空隙填充物的需求;不断增加;外科医生管理;治疗骨病;必不可少的工具
  • 203.聚焦Claudin18.2:国产企业领航全球研发,蓝海市场方兴未艾

    [医药制造业] [2024-07-31]

    Claudin18.2 是 CLDN 蛋白质家族的一个亚型,一般情况下仅在分化的胃黏膜上皮细胞上表达,维持胃黏膜的屏障功能。而在胃上皮组织恶性转化过程中,细胞极性的扰动导致 CLDN18.2 表 位在细胞表面暴露,CLDN18.2 在特定肿瘤组织中稳定表达,胃癌中表达率高达 80-90%,胰 腺癌表达率超过 60%。日本安斯泰来的 Zolbetuximab 单抗成功上市验证了该靶点的成药性,成为全球第一款获批的 CLDN18.2 药物。

    关键词:Claudin18.2 ;单抗;ADC
  • 204.2024H2 美股 Biotech 临床催化事件梳理与案例解析

    [医药制造业] [2024-07-31]

    临床数据是 Biotech 股价变化的重要催化之一。未商业化的 Biotech 公司最大的价值取决于临床管线,临床数据读出往往成为股价变化的重要催化,现整理美股部分 Biotech 公司 2024 年下半年预期公布的临床试验数据,跟踪海外公司的临床试验数据读出同样可以成为我们跟踪海外前沿进展的有效线索。


    关键词:临床数据;Biotech;CETP 抑制剂
  • 205.Q3 重点关注结构性机会,Q4 期待阶段性景 气周期

    [医药制造业] [2024-07-31]

    自 2022 年俄乌冲突以来,我们团队一直关注欧洲化工品产能退出带来的投资 机会,其中最典型的产品就是欧洲供给占大头的维生素行业。然而因为供给过 剩和海外自 2022 年开启的去库周期的影响,维生素板块的行情姗姗来迟。2024年,一方面是需求端海外补库叠加国内养殖利润好转,一方面是供给端海外巨 头对维生素板块的剥离和减产,我们认为维生素板块迎来了重要的投资时点。
    关键词:Q3 重点关注结构性机会,Q4 期待阶段性景 气周期
  • 206.全球维生素 B12 市场研究预测报告(2023-2028年)

    [医药制造业] [2024-07-30]

    The increasing popularity of vegetarian and vegan diets, particularly in countries like the US, India, etc has generated a high demand for Vitamin B 12 supplements to fulfill the nutritional requirements as vegan diets are low in Vitamin B 12 content The growing number of individuals following plant based diets has resulted in a widespread deficiency of Vitamin B 12 among the population, creating a strong demand for Vitamin B 12 across the globe In response to this, companies like Accord Healthcare, EverlyWell etc are increasingly introducing new more potent ranges of Vitamin B 12 supplements to cure patients' pernicious anemia gastrointestinal dysfunction

    关键词:素食;纯素食饮食;维生素 B 12 ;补充剂;满足营养需求
  • 207.美国全球眼底照相机市场报告2030年

    [计算机、通信和其他电子设备制造业,医药制造业,仪器仪表制造业] [2024-07-30]

    The global fundus camera market is estimated to grow at a CAGR of 7.9% from 2022 to 2030. Key factors driving the market growth are increase in diabetic retinopathy screening procedures and launches of innovative products. However, incorrect clinical diagnosis due to distorted fundus photography hinders the market growth.

    关键词:全球眼底照相机市场;复合年增长率;糖尿病视网膜病变;筛查程;增加和创新产品
  • 208.美国全球脑脊液管理市场报告2030年

    [医药制造业] [2024-07-30]

    The global cerebrospinal fluid management market is estimated to grow at a CAGR of 5.3% from 2022 to 2030. Key factors driving the market growth are increasing incidences of CSF leak and growing developments for CSF management products. However, the risk associated with CSF shunts hinders the market growth.

    关键词:全球脑脊液管理市场;增长率增长;脑脊液漏出率;增加;脑脊液管理产品;不断发展;阻碍;市场的增长
  • 209.生物产业研究报告

    [医药制造业] [2024-07-30]

    截至 2024年 5月底,2024年全国共成立生物医药企业 636659家;其中,5月新增企业 93688家,环比上月下降 70.18% 。从新增企业地域分布来看,企业数量排名前十的省份广东省、湖北省、山东省、江苏省、河南省、浙江省、河北省、四川省、安徽省、北京市,占全国新增企业总量的 17.07% 。

    关键词:生物医药企业;沪市生物医药;白蛋白、Ⅷ因子、 PCC
  • 210.美国全球减肥手术市场报告2030年

    [医药制造业] [2024-07-30]

    The Global bariatric surgeries market is estimated to grow at a CAGR of 15.9% from 2022 to 2030. Key factors driving the market growth are the increasing prevalence of obesity and growing demand for minimally invasive surgeries are driving the market growth. However, the stringent regulatory policies and increase in safety concerns restrain the market growth.

    关键词:全球减肥手术市场;增长率增长;肥胖症患病率;上升;微创手术的需求;不断增长
首页  上一页  ...  16  17  18  19  20  21  22  23  24  25  ...  下一页  尾页  
© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服